Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.
复制标题
DOI：
10.1053/j.gastro.2018.08.063
复制
发表时间：
2019-01
期刊：
影响因子：
29.4
通讯作者：
Sandler RS
中科院分区：
文献类型：
--
作者：
Peery AF;Crockett SD;Murphy CC;Lund JL;Dellon ES;Williams JL;Jensen ET;Shaheen NJ;Barritt AS;Lieber SR;Kochar B;Barnes EL;Fan YC;Pate V;Galanko J;Baron TH;Sandler RS
疾病负担的估计可以为国家的研究、临床护理和政策提供信息。我们的目的是估计美国胃肠道（GI）（包括管腔，肝脏和胰腺）疾病的医疗保健使用和支出。我们根据商业和医疗保险补充计划的最新行政索赔、GI质量改善联盟登记处和国家数据库的数据估计了医疗保健使用和支出。2015年，用于胃肠道疾病的年度医疗保健支出总额为1359亿美元。肝炎（233亿美元）、食管疾病（181亿美元）、胆道疾病（103亿美元）、腹痛（102亿美元）和炎症性肠病（72亿美元）是最昂贵的。每年，有超过5440万次门诊就诊，主要诊断为胃肠道疾病，300万次住院，540，500次全因30天再入院。有266，600例新诊断的胃肠道癌症病例和144，300例癌症死亡。每年有97，700人死于非恶性胃肠道疾病。估计每年进行1100万次结肠镜检查、610万次上消化道内镜检查、313，000次柔性乙状结肠镜检查、178，400次上消化道内镜超声检查和169，500次内镜逆行胰胆管造影术。在50-75岁接受结肠镜检查的平均风险人群中，34.6%有1个或多个腺瘤性息肉，4.7%有1个或多个晚期腺瘤性息肉，5.7%有1个或多个锯齿状息肉切除。在美国，胃肠道疾病对医疗保健的使用贡献很大。每年用于胃肠道疾病的总支出为1359亿美元，高于其他常见疾病。支出可能会继续增加。
Estimates of disease burden can inform national health priorities for research, clinical care, and policy. We aimed to estimate health care use and spending among gastrointestinal (GI) (including luminal, liver, and pancreatic) diseases in the United States. We estimated health care use and spending based on the most currently available administrative claims from commercial and Medicare Supplemental plans, data from the GI Quality Improvement Consortium Registry, and national databases. In 2015, annual health care expenditures for gastrointestinal diseases totaled $135.9 billion. Hepatitis ($23.3 billion), esophageal disorders ($18.1 billion), biliary tract disease ($10.3 billion), abdominal pain ($10.2 billion), and inflammatory bowel disease ($7.2 billion) were the most expensive. Yearly, there were more than 54.4 million ambulatory visits with a primary diagnosis for a GI disease, 3.0 million hospital admissions, and 540,500 all-cause 30-day readmissions. There were 266,600 new cases of GI cancers diagnosed and 144,300 cancer deaths. Each year, there were 97,700 deaths from non-malignant GI diseases. An estimated 11.0 million colonoscopies, 6.1 million upper endoscopies, 313,000 flexible sigmoidoscopies, 178,400 upper endoscopic ultrasound examinations, and 169,500 endoscopic retrograde cholangiopancreatography procedures were performed annually. Among average-risk persons ages 50–75 years who underwent colonoscopy, 34.6% had 1 or more adenomatous polyps, 4.7% had 1 or more advanced adenomatous polyps, and 5.7% had 1 or more serrated polyps removed. GI diseases contribute substantially to health care use in the United States. Total expenditures for GI diseases are $135.9 billion dollars annually—greater than for other common diseases. Expenditures are likely to continue increasing.
登录
查看更多内容
影响因子：
6.2
作者：
Joseph DA;Meester RG;Zauber AG;Manninen DL;Winges L;Dong FB;Peaker B;van Ballegooijen M
通讯作者：
van Ballegooijen M
影响因子：
158.5
作者：
Alter, MJ;Kruszon-Moran, D;Margolis, HS
通讯作者：
Margolis, HS
2001-2013 年美国退伍军人肝硬化和肝细胞癌负担趋势（按肝脏疾病分类
影响因子：
29.4
作者：
Beste, Lauren A.;Leipertz, Steven L.;Ioannou, George N.
通讯作者：
Ioannou, George N.
影响因子：
39.2
作者：
Denniston MM;Jiles RB;Drobeniuc J;Klevens RM;Ward JW;McQuillan GM;Holmberg SD
通讯作者：
Holmberg SD
DOI：
10.1056/nejmoa1309086
发表时间：
2014-04-03
期刊：
The New England journal of medicine
影响因子：
--
作者：
Corley DA;Jensen CD;Marks AR;Zhao WK;Lee JK;Doubeni CA;Zauber AG;de Boer J;Fireman BH;Schottinger JE;Quinn VP;Ghai NR;Levin TR;Quesenberry CP
通讯作者：
Quesenberry CP